ir.akebia.com
Investors - Akebia TherapeuticsThe Investor Relations website contains information about Akebia Therapeutics business for stockholders, potential investors, and financial analysts.
http://ir.akebia.com/
The Investor Relations website contains information about Akebia Therapeutics business for stockholders, potential investors, and financial analysts.
http://ir.akebia.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.4 seconds
16x16
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
9
SITE IP
206.200.251.19
LOAD TIME
0.359 sec
SCORE
6.2
Investors - Akebia Therapeutics | ir.akebia.com Reviews
https://ir.akebia.com
The Investor Relations website contains information about Akebia Therapeutics business for stockholders, potential investors, and financial analysts.
ir.akebia.com
Printed Materials - Akebia Therapeutics
http://ir.akebia.com/printed-materials.cfm
No documents are currently available to order by mail. 4:00 PM ET Nov 2, 2016. Delayed 20 min.,.
Events & Presentations - Akebia Therapeutics
http://ir.akebia.com/eventdetail.cfm?EventID=161007
Jefferies 2015 Global Healthcare Conference. Jun 1, 2015. Speaker: John P. Butler, President and Chief Executive Officer. File is in Briefcase. 4:00 PM ET Nov 2, 2016. Delayed 20 min.,.
Events & Presentations - Akebia Therapeutics
http://ir.akebia.com/events.cfm
Nov 7, 2016. Credit Suisse 25th Annual Healthcare Conference. Credit Suisse 25th Annual Healthcare Conference. Please sign up for email alert notification. Sep 13, 2016. Morgan Stanley Global Healthcare Conference. Speaker: John P. Butler, President and Chief Executive Officer. Sep 12, 2016. 18th Annual Rodman and Renshaw Global Investment Conference. Speaker: John P. Butler, President and Chief Executive Officer. File is in Briefcase. Jul 12, 2016. 2nd Annual Cantor Fitzgerald Healthcare Conference.
Corporate Governance - Akebia Therapeutics
http://ir.akebia.com/corporate-governance.cfm
File is in Briefcase. File is in Briefcase. Nominating and Governance Committee Charter. File is in Briefcase. File is in Briefcase. Code of Business Ethics and Conduct. File is in Briefcase. File is in Briefcase. Add file to Briefcase. 4:00 PM ET Nov 2, 2016. Delayed 20 min.,.
SEC Filings - Akebia Therapeutics
http://ir.akebia.com/sec.cfm
All Filings (excluding Section 16). Oct 4, 2016. File is in Briefcase. Oct 4, 2016. File is in Briefcase. Oct 4, 2016. Hadas, nicole r. File is in Briefcase. Sep 20, 2016. File is in Briefcase. Aug 8, 2016. File is in Briefcase. Aug 2, 2016. File is in Briefcase. Aug 2, 2016. Canute, scott a. File is in Briefcase. Aug 2, 2016. File is in Briefcase. Jul 28, 2016. File is in Briefcase. Jul 7, 2016. File is in Briefcase. 10 results per page. 25 results per page. 50 results per page. Add PDF file to Briefcase.
TOTAL PAGES IN THIS WEBSITE
20
About Us | Akebia Therapeutics
http://akebia.com/about
Global leadership in hypoxia inducible factor (HIF) biology. Dedicated to advancing care for serious disease. ELEVATION 5,300 ft. Canton of Bern, Switzerland. HIF biology has far-reaching potential. Pursuing advances across multiple disease states. We were founded in 2007 to discover and develop novel therapeutic solutions leveraging hypoxia inducible factor or HIF biology, a primary regulator involved in multiple major biological pathways. Pursuing advances across multiple disease states. We launched a ...
Career Opportunities | Akebia Therapeutics
http://akebia.com/about/careers
Take your careers to hew heights @Akebia. What makes your work meaningful? Rediscover your passion @Akebia. How far can you go? Ldquo;We’re on the verge of something big.”. Elizabeth Bonilla, Associate Director, Finance. Ldquo;I never thought a company like this existed. It’s a job unicorn.”. Nancy Brennan, Senior Patent Counsel. Ldquo;HIF science is an incredibly exciting area that could impact human health for decades to come.”. Humann Hodjatzadeh, Associate Director, Finance.
Research & Development Pipeline | Akebia Therapeutics
http://akebia.com/programs
Elevating the promise of hypoxia inducible factor (HIF) based therapeutics. ELEVATION 5,250 ft. HIF regulation could have therapeutic uses across a variety of conditions. Our HIF-based product pipeline. Abbreviations: DD-CKD, dialysis-dependent chronic kidney disease; NDA, New Drug Application; NDD-CKD, non dialysis-dependent chronic kidney disease. For more information on our currently enrolling studies, please visit www.clinicaltrials.gov. Global leadership in HIF biology. ANEMIA SECONDARY TO CKD.
News and Press Information | Akebia Therapeutics
http://akebia.com/media
Access media assets, breaking news, press releases, and scientific publications. Explore this page for media resources, including a press kit, current news, and press releases. To sign up for breaking news alerts, register here. For media inquiries, please contact us at Media@Akebia.com. Includes logos, leadership photography and bios. Download all media kit assets (ZIP file, 5.5 MB). John Butler (President and CEO) photos and biography. Monday, August 8, 2016. Monday, August 8, 2016. Phase 2 Study of AK...
TOTAL LINKS TO THIS WEBSITE
9
AIG - Investor Information
070109 AIG COMPLETES SALE OF 21ST CENTURY INSURANCE TO ZURICH FINANCIAL SERVICES GROUP UNIT. 070109 AIG IN AGREEMENT TO SELL ITS CONSUMER FINANCE OPERATIONS IN COLOMBIA. 062909 AIG TO SELL ITS RUSSIAN BANK SUBSIDIARY TO BANQUE PSA FINANCE.
Investor Overview - Investor Relations - Aimmune
CODIT and Oral Immunotherapy. AR101 for Peanut Allergy. Stock Quote and Chart. Aimmune Therapeutics a 35th Annual J.P. Morgan Healthcare Conference. 160;at 5:00 pm PT. Aimmune Therapeutics a 35th Annual J.P. Morgan Healthcare Conference. Wednesday, January 11, 2017 . 5:00 pm PT . Click here for webcast. Click here to add this event to your calendar. January 4, 2017. Aimmune Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference. December 1, 2016. Aimmune Therapeutics Appoints Scien...
airberlin IR – Investor Relations
Creditor Relations - Anleihen. Raquo; Investor Relations. Airberlin-Aktie, XETRA: 0,04 EUR, 29.03.2018, 17:35. Creditor Relations - Anleihen. Geplanter Erwerb der NIKI Luftfahrt GmbH durch die Deutsche. NIKI Luftfahrt GmbH hat Antrag auf Eröffnung eines. Geplanter Erwerb der NIKI Luftfahrt GmbH durch die Deutsche.
AirMedia Group Inc. - Investor Relations - Investor Relations Home
Stock Quote and Chart. Press Releases and Events. First Quarter 2015 Unaudited Financial Results. AirMedia 2014 20-F Filing. AirMedia Special Committee Appoints Advisors. AirMedia Announces Receipt of Preliminary Non-Binding "Going Private" Proposal. AirMedia Reaches Definitive Agreement to Sell 75% Equity Interest of its Advertising Business for RMB2.1 Billion. AirMedia Obtains Wi-Fi Concession Right on Ordinary Trains Operated by Beijing Railway Bureau. There are currently no events scheduled. 15/F, Sk...
Investors Home | Investor Relations | Akamai
Skip to main content. State of the Internet. Web and Mobile Performance. Akamai is the global leader in Content Delivery Network (CDN) services, making the internet fast, reliable and secure for its customers. The company’s advanced web performance, mobile performance, cloud security and media delivery solutions are revolutionizing how businesses optimize consumer, enterprise and entertainment experiences for any device, anywhere. Learn about our commitment to responsible corporate governance. US Toll Fr...
Investors - Akebia Therapeutics
ELEVATION 5,250 ft. HIF regulation could have therapeutic uses across a variety of conditions. We are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease. Aug 11, 2015. Akebia Announces Second Quarter 2015 Financial Results. Jun 16, 2015. Akebia to Present at the 2015 JMP Securities Life Sciences Conference. View all press releases ».
Investor Relations | Akers Biosciences, Inc.
The Company is incorporated in the United States in the State of New Jersey where all corporate operations currently reside. The rights of shareholders may be different from the rights of shareholders in a UK incorporated company. There are no restrictions on the trading of ABI's shares on AIM . Day High: 3.86. Day Low: 3.77. Aug 14, 2015. Delayed 20 min., by eSignal. Day High: 245.25. Day Low: 245.00. Aug 14, 2015. Delayed 20 min., by eSignal. Aug 14, 2015. Aug 13, 2015. View all press releases ».
Investor Relations - Investor Relations
Your partner in aquaculture technology. AKVA group is the global leader in delivering technology to the aquaculture industry. The shares of AKVA group are traded on the Oslo Stock Exchange from November 2006. The company will strive to provide the market with relevant information according to the current regulations. It will always be an objective to give correct, relevant and timely information to all market participants at the same time. AKVA group ASA : 1Q 2015 financial reporting. Tel 47 916 39 831.
Investor Relations - Investor Relations - Albany International Corp.
Q2 2015 Albany International Corp Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Albany International Corp Earnings Conference Call. Wednesday, August 5, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. Q3 2014 Albany International Corp Earnings Conference Call. Tuesday, November 4, 2014 9:00 am ET. Q3 2014 Financial Results. Q3 2014 Earnings Call Presentation. Albany International Reports Second-Quarter Results. Tuesday, August 4, 2015 - 5:00 pm. Replicat...
Investors - Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics is a clinical-stage biotechnology company focused primarily on the development of products to treat diseases thought to be related to endogenous free aldehydes, a naturally occurring class of toxic molecules. The company has developed NS2, a product candidate designed to trap free aldehydes. Aldeyra has initiated clinical testing of NS2 for the treatment of Sjögren-Larsson Syndrome and noninfectious anterior uveitis. Aldeyra Therapeutics Corporate Presentation - August 2015. Aldeyra ...
Alexion Pharmaceuticals, Inc. - Investor Relations
Europe, the Middle East and Africa. Sponsored Research and Collaborations. Last $ 189.62. 080715 4:00 PM ET. Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015. Thu, 30 Jul, 2015 - 10:00 AM ET Listen to Webcast ». 2Q 2015 Earnings Slides. Please see Full Prescribing Information. And Important Safety Information.
SOCIAL ENGAGEMENT